A multicenter, cooperative, randomized, comparative study regarding the efficacy of denosumab for bone loss related to postoperative endocrine therapy in postmenopausal patients with hormone-sensitive breast cancer

Trial Profile

A multicenter, cooperative, randomized, comparative study regarding the efficacy of denosumab for bone loss related to postoperative endocrine therapy in postmenopausal patients with hormone-sensitive breast cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Denosumab (Primary) ; Aromatase inhibitors
  • Indications Early breast cancer; Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 May 2017 Status changed from not yet recruiting to recruiting.
    • 23 Nov 2016 Planned initiation date changed from 1 Aug 2016 to 15 Dec 2016.
    • 11 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top